Clash Of The LVADs: Continuous Flow Devices Moved To Lower-Paying DRG

MicroMed is seeking to regain sufficient inpatient reimbursement for its DeBakey left-ventricular assist device by the time Medicare coverage for LVADs as destination therapy becomes effective